SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001493152-24-024517
Filing Date
2024-06-20
Accepted
2024-06-20 16:15:08
Documents
4
Period of Report
2024-06-20

Document Format Files

Seq Description Document Type Size
1 formpre14a.htm PRE 14A 383688
2 formpre14a_001.jpg GRAPHIC 27613
3 proxy_001.jpg GRAPHIC 254048
4 proxy_002.jpg GRAPHIC 166828
  Complete submission text file 0001493152-24-024517.txt   1003025
Mailing Address 855 N. WOLFE STREET SUITE 601 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 601 BALTIMORE MD 21205 856-848-8698
MyMD Pharmaceuticals, Inc. (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36268 | Film No.: 241056387
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)